Discover 885 paid clinical trials in El Paso, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
El Paso offers a variety of clinical research opportunities focused on conditions such as asthma, diabetes, arthritis, and Parkinson’s disease. The city’s growing healthcare sector is actively recruiting participants, providing access to cutting-edge treatments for both healthy volunteers seeking paid research studies and individuals looking for trials targeting specific health conditions.
Filter
2
Filter results
Results: 885
Active & Responsive
Comprehensive HHT Outcomes Registry of the United States (CHORUS)
for
Hereditary Hemorrhagic Telangiectasia,
Location: Aurora CO, Salt Lake City UT, Dallas TX, Rochester MN,
Sponsor: Cure HHT
Sex: All
Age: 0+
Code: NCT06259292
Recruiting
Active & Responsive
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
for
Glioblastoma
Location: Aurora CO, Salt Lake City UT, Minneapolis MN, Orange CA,
Sponsor: Global Coalition for Adaptive Research
Sex: All
Age: 18+
Code: NCT03970447
Phase 2, Phase 3, Recruiting
Active & Responsive
OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
for
Eosinophilic Gastrointestinal Disorders (EGIDs),
Location: Aurora CO, Denver CO, Salt Lake City UT, Phoenix AZ,
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 3+
Code: NCT02523118
Recruiting
Active & Responsive
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Location: Denver CO, Salt Lake City UT, Kansas City KS, Dallas TX,
Sponsor: Anagram Therapeutics, Inc.
Sex: All
Age: 12+
Code: NCT07450547
Phase 2, Recruiting
Active & Responsive
Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
for
Cystic Fibrosis
Location: Denver CO, Aurora CO, Kansas City KS, Dallas TX,
Sponsor: Boston Children's Hospital
Sex: All
Age: 6+
Code: NCT06683092
Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
for
Breast Neoplasms
Location: Denver CO, Aurora CO, Kansas City MO, Gilbert AZ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06312176
Phase 3, Recruiting
Active & Responsive
Study of DONQ52 in Active Celiac Disease
for
Celiac Disease
Location: Denver CO, Colorado Springs CO, Sandy City UT,
Sponsor: Chugai Pharmaceutical
Sex: All
Age: 18 - 70+
Code: NCT07239336
Phase 2, Recruiting
Active & Responsive
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
for
Major Depressive Disorder (MDD),
Location: Denver CO, Salt Lake City UT, Lincoln NE, Las Vegas NV,
Sponsor: ACADIA Pharmaceuticals Inc.
Sex: All
Age: 18 - 65
Code: NCT07284667
Phase 2, Recruiting
Active & Responsive
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
for
Hyperphosphatemia,
Location: Denver CO, Albuquerque NM, Kansas City MO, Las Vegas NV,
Sponsor: R1 Therapeutics
Sex: All
Age: 18+
Code: NCT06712654
Phase 2, Recruiting
Active & Responsive
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
for
HIV-1-infection
Location: Denver CO, Sante Fe NM, Salt Lake City UT,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT07645287
Phase 2, Recruiting
Active & Responsive
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
for
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Location: Denver CO, Kansas City MO, Fort Worth TX, Dallas TX,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07266831
Phase 2, Phase 3, Recruiting
Active & Responsive
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
for
Primary Sjogren's Disease
Location: Denver CO, Fort Collins CO, Amarillo TX, Flagstaff AZ,
Sponsor: Vor Biopharma
Sex: All
Age: 18 - 70+
Code: NCT07404865
Phase 3, Recruiting
Active & Responsive
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)